In the last trading session, 2.03 million shares of the Acadia Pharmaceuticals Inc (NASDAQ:ACAD) were traded, and its beta was 0.59. Most recently the company’s share price was $22.19, and it changed around $0.21 or 0.96% from the last close, which brings the market valuation of the company to $3.71B. ACAD currently trades at a discount to its 52-week high of $25.23, offering almost -13.7% off that amount. The share price’s 52-week low was $13.40, which indicates that the current value has risen by an impressive 39.61% since then.
Acadia Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.85. If we narrow it down even further, the data shows that 0 out of 21 analysts rate the stock as a Sell; another 6 rate it as Overweight. Among the rest, 7 recommended ACAD as a Hold, whereas 7 deemed it a Buy, and 1 rated it as Underweight.
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) trade information
Instantly ACAD has showed a green trend with a performance of 0.96% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 22.77 on recent trading dayincreased the stock’s daily price by 2.55%. The company’s shares are currently up 20.93% year-to-date, but still up 0.91% over the last five days. On the other hand, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) is 50.64% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $24, which translates to bulls needing to increase their stock price by 7.54% from its current value. Analyst projections state that ACAD is forecast to be at a low of $20 and a high of $32.
Acadia Pharmaceuticals Inc earnings are expected to increase by -61.74% in 2025, but the outlook is positive 4.75% per year for the next five years.
ACAD Dividends
Acadia Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 8.2827% or 13.71 million shares worth $222.82 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Apr 30, 2025 . The former held 7.48 shares worth $166.02 million, making up 4.47% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 3.85 shares worth around $85.4 million, which represents about 2.30% of the total shares outstanding.
